The impact of Brexit on the pharmaceutical and medical device industries

Our European Life Sciences Regulatory team has been examining the potential consequences of Brexit for the pharmaceutical and medical device industries since before the results of the referendum were known. We have been working diligently with our clients and experts in other fields to compile a global view of the risks and opportunities that Brexit will present.

During this webinar, we will provide a detailed update on recent developments and a guide to the potential issues that may arise in the two months leading up to the United Kingdom's exit on 29 March 2019. Specifically tailored for pharmaceutical and medical device companies, we will discuss the major issues to be addressed, what this means for your business, and how you can prepare for Brexit.

Topics will include:

  • What's going to happen to your business? Insights on the key impacts of Brexit for the life sciences and health care industry.
  • Update on latest developments including potential next steps.
  • Why is Brexit relevant, especially for companies not based in the United Kingdom?
  • Immediate "to-dos" for now and how can we support you.
  • Opportunities and challenges with the relocation of the European Medicines Agency (EMA).
  • FAQs about Brexit and the industry.

Click here to register for this complimentary webinar.

Back To Listing
Loading data